← Eichor
Condition: Stage Iii Endometrial Carcinoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Stage Iii Endometrial Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemothera
NA · 1 location(s) · Dana-Farber Cancer Institute · NCT04997096Randomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endo
Phase 3 · 15 location(s) · Gustave Roussy, Cancer Campus, Grand Paris · NCT06712472ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
NA · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07270666Early Detection of Endometrial/Ovarian Cancer and Hereditary Predisposition of These Cancers
NA · 2 location(s) · McGill University · NCT04891029Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
Phase N/A · 1 location(s) · Mayo Clinic · NCT07062016PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer
Phase N/A · 1 location(s) · Radboud University Medical Center · NCT03621904Prehabilitation in Gynaecological Cancer Patients
Phase 3 · 1 location(s) · Charles University, Czech Republic · NCT04789694Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer
Phase 3 · 17 location(s) · Hutchmed · NCT06584032Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Phase 3 · 55 location(s) · NRG Oncology · NCT05646316An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV
NA · 1 location(s) · Roswell Park Cancer Institute · NCT06855706Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · 409 location(s) · National Cancer Institute (NCI) · NCT05256225Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel i
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT05092373Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With
Phase 3 · 242 location(s) · National Cancer Institute (NCI) · NCT07198074PROfiling Based Endometrial Cancer Adjuvant Therapy
NA · 10 location(s) · Women's Hospital School Of Medicine Zhejiang University · NCT05179447Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The Co
Phase 2 · 483 location(s) · National Cancer Institute (NCI) · NCT05564377A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer
EARLY_Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05691010Vaginal Cuff Brachytherapy Fractionation Study
Phase 3 · 3 location(s) · Kara Romano, MD · NCT03785288A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Ute
Phase 3 · 171 location(s) · BioNTech SE · NCT06340568European Collaborative Multicenter Observational Study: Modular Treatment With PMMR and Targeted Compartmental Pelvic Ly
Phase N/A · 1 location(s) · Dr. Paul Buderath · NCT04504006IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT05039801DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Tre
Phase 3 · 250 location(s) · AstraZeneca · NCT06989112Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
Phase N/A · 3 location(s) · Mayo Clinic · NCT06349642Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Mayo Clinic · NCT05269381A Study of a Weight Loss Intervention in People With Endometrial Cancer
EARLY_Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06751589Sentinel Node Biopsy in Endometrial Cancer
Phase 3 · 19 location(s) · Queensland Centre for Gynaecological Cancer · NCT04073706
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.